AMPH
Amphastar Pharmaceuticals, Inc.
23.60$
-0.8%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 75.6% | 69.2% | 59.2% | 62.2% | 63.7% | 59.1% | 59.0% | 54.4% | 50.1% | 45.5% | 48.9% | 50.5% | |
| 24.4% | 30.8% | 40.8% | 37.8% | 36.3% | 40.9% | 41.0% | 45.6% | 49.9% | 54.5% | 51.1% | 49.5% | |
| 13.5% | 14.7% | 16.1% | 18.1% | 19.5% | 21.4% | 19.2% | 13.9% | 15.0% | 11.4% | 10.1% | 11.9% | |
| 16.5% | 16.5% | 16.4% | 18.5% | 16.9% | 15.6% | 14.4% | 11.7% | 9.0% | 8.0% | 7.7% | 11.9% | |
| 32.7% | 33.4% | 34.7% | 39.3% | 39.2% | 40.9% | 37.8% | 29.7% | 28.3% | 23.9% | 23.0% | 30.0% | |
| -8.5% | -2.7% | 6.1% | -0.4% | -2.9% | 0.0% | 3.1% | 16.0% | 21.5% | 30.6% | 28.1% | 19.5% | |
| 0.3% | 0.4% | 0.4% | 0.3% | 0.1% | 0.0% | 0.1% | 0.2% | 0.4% | 4.2% | 4.1% | 3.5% | |
| -8.6% | -4.1% | 5.9% | 0.7% | -3.4% | 18.7% | 1.3% | 19.2% | 23.0% | 26.3% | 25.8% | 17.2% | |
| -3.5% | -3.0% | 1.7% | -1.2% | -1.1% | 4.3% | 1.0% | 4.7% | 4.7% | 4.9% | 4.1% | 3.5% | |
| -5.1% | -1.1% | 4.1% | 1.9% | -1.9% | 15.2% | 0.4% | 14.2% | 18.3% | 21.3% | 21.8% | 13.6% | |
| -1.5% | 1.5% | 11.9% | 5.0% | 2.7% | 6.5% | 8.6% | 25.5% | 29.3% | 37.3% | 37.9% | 29.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.